Combination therapy with cisplatin and anti-4-1BB: synergistic anticancer effects and amelioration of cisplatin-induced nephrotoxicity.

Cancer Research
Young H KimByoung S Kwon

Abstract

Anti-4-1BB and cisplatin showed synergistic anticancer effects in the CT-26 colon carcinoma model, producing complete regression in >60% of mice with either preventive or therapeutic treatment. The tumor-free mice formed long-lasting CD8(+) T cell-dependent tumor-specific memory. Anti-4-1BB induced rapid repopulation of T and B cells from cisplatin-mediated lymphopenia and differentiation and expansion of IFN-gamma(+)CD11c(+)CD8(+) T cells. Cisplatin facilitated expansion of naïve, effector, and memory CD8(+) T cells; combination therapy produced almost twice as many lymphoid cells as anti-4-1BB alone. Cisplatin increased 4-1BB on antigen-primed T cells and induced 4-1BB de novo on kidney tubular epithelium. Cross-linking of 4-1BB protected the T cells and kidney epithelium from cisplatin-mediated apoptosis by increasing expression of antiapoptotic molecules. Thus, cisplatin-induced 4-1BB provided a mechanism for amelioration of the lymphopenia and nephrotoxicity inherent in cisplatin treatment. We concluded that chemoimmunotherapy with anti-4-1BB and cisplatin is synergistic in tumor killing and prevention of organ-specific toxicity.

References

Nov 1, 1986·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·F Ries, J Klastersky
Jan 20, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D Lebwohl, R Canetta
Sep 18, 2002·The Journal of Clinical Investigation·Robert W Schrier
Oct 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hyeon-Woo LeeByoung S Kwon
May 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anna K NowakBruce W S Robinson
Oct 7, 2003·Cellular Immunology·Hyeon-Woo LeeByoung S Kwon
May 3, 2005·Nature Reviews. Cancer·Richard A Lake, Bruce W S Robinson
Apr 6, 2007·Kidney International·Q WeiZ Dong

❮ Previous
Next ❯

Citations

Aug 10, 2010·The Cancer Journal·Jedd D WolchokJeffrey S Weber
Sep 9, 2009·Pigment Cell & Melanoma Research·Camilla JandusPedro Romero
Jan 5, 2010·Immunotherapy·Angela D PardeeWalter J Storkus
Oct 3, 2015·Expert Opinion on Therapeutic Targets·Dass S Vinay, Byoung S Kwon
Nov 16, 2010·Seminars in Oncology·Paolo A AsciertoIgnacio Melero
Jan 17, 2016·European Journal of Immunology·Alfonso R Sanchez-PauleteIgnacio Melero
Aug 8, 2009·Clinical and Experimental Immunology·K S PeggsJ P Allison
Mar 24, 2010·International Journal of Cancer. Journal International Du Cancer·Juan DubrotIgnacio Melero
Jun 25, 2015·Frontiers in Oncology·Todd Bartkowiak, Michael A Curran
Apr 16, 2014·Frontiers in Oncology·Laetitia MaugeDominique Helley
May 11, 2016·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Hyunseong KimHyunsu Bae
Jul 25, 2015·Nature Reviews. Cancer·Ignacio MeleroJohn Haanen
Oct 7, 2020·Journal for Immunotherapy of Cancer·Yeonjoo ChoiJoud Hajjar
Mar 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ignacio MeleroPaolo A Ascierto
Mar 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ignacio MeleroJedd D Wolchok
Sep 20, 2017·Cancer Research·Sang W KangByungsuk Kwon
Nov 30, 2018·Chemical Reviews·Bernhard EnglingerWalter Berger
Mar 4, 2022·Journal for Immunotherapy of Cancer·Javier Glez-VazIgnacio Melero

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis